Vulvar vestibulitis: response to hypocontactant vulvar therapy

Area of Science:

• Dermatology
• Gynecology
• Pain Management

Background:

• Vulvar vestibulitis syndrome (VVS) is a chronic pain condition affecting women.
• Dyspareunia and vulvar pain significantly impact quality of life.

Purpose of the Study:

• To evaluate the clinical efficacy of a hypocontactant vulvar skin regimen for VVS.
• To assess the impact of the regimen on vulvar pain and dyspareunia.

Main Methods:

• A clinical trial involving 85 women diagnosed with VVS.
• Patients followed a hypocontactant vulvar skin regimen for at least four months.
• Clinical assessments and questionnaires tracked pain reduction and dyspareunia improvement over 6-36 months.

Main Results:

• A 77% overall response rate for vulvar pain reduction was observed at six months.
• This included 20% complete response and 57% partial response.
• 60% of patients reported improvement in dyspareunia levels.

Conclusions:

• A hypocontactant vulvar skin regimen shows significant clinical benefit for VVS patients.
• These findings suggest that contact irritants may play a role in VVS.
• Further research into irritant avoidance is warranted.